British pharma giant AstraZeneca has announced to acquire radio-conjugate specialist Fusion Therapeutics Inc...
Up To Date
Latest News
Exeter-based university spin-out Senisca Ltd has added £3.7m seed money to a £1.1m not dilutive funding to...
French endocrine diseases specialist Amolyt Pharma SA has entered into a take-over agreement by AstraZeneca.
London-based virtual drug discovery specialist Relation Therapeutics Ltd has closed another US$35m seed...
TREM2, a receptor on the surface of macrophages, reduces necrotic core formation in early atherosclerosis, a...
British companies Arecor Therapeutics plc and TRx Biosciences Ltd combine their technologies to formulate an...